Skip to content
akaturk Academic measurement
Sign in Register

Academician

MERVE KARAYEL BAŞAR

DOKTOR ÖĞRETİM ÜYESİ

BAHÇEŞEHİR ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyokimya

A quick look at recorded outputs — details below.

  • Articles 9
  • Projects 0
  • Books 0
  • Proceedings 0
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 12 Q2 8 Q3 0 Q4 0
WoS (JCR) Q1 4 Q2 9 Q3 7 Q4 0
TR Index 2 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 4
Avg percentile 70.0%
Top 1% share 0.0%
Top 10% share 20.0%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

9 publications total

Scopus (SJR)
Q1 12 Q2 8 Q3 0 Q4 0
WoS (JCR)
Q1 4 Q2 9 Q3 7 Q4 0
TR Index
2 articles

Article list

  1. 2024 O-demethyl Galantamine Alters Protein Expression in Cerebellum of 5xFAD Mice TURKISH JOURNAL OF BIOLOGY DOI 10.55730/1300-0152.2692 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 4.6%
  2. 2024 O-demethyl Galantamine Alters Protein Expression in Cerebellum of 5xFAD Mice TURKISH JOURNAL OF BIOLOGY DOI 10.55730/1300-0152.2692 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 4.6%
  3. 2023 Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI ALZHEIMERS & DEMENTIA DOI 10.1002/alz.13008 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 93.3%
  4. 2023 Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) imaging EUROPEAN JOURNAL OF NEUROSCIENCE DOI 10.1111/ejn.16103 YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.1%
  5. 2023 Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine BIOMEDICINE & PHARMACOTHERAPY DOI 10.1016/j.biopha.2022.114111 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.1%
  6. 2023 Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) imaging EUROPEAN JOURNAL OF NEUROSCIENCE DOI 10.1111/ejn.16103 YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.1%
  7. 2023 Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI ALZHEIMERS & DEMENTIA DOI 10.1002/alz.13008 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 93.3%
  8. 2022 Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain MOLECULAR OMICS DOI 10.1039/d1mo00440a YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
  9. 2022 Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain MOLECULAR OMICS DOI 10.1039/d1mo00440a YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
  10. 2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD\nAlzheimer\u2019s Disease Mouse Model Current Medicinal Chemistry DOI 10.2174/0929867328666210827152914 YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
  11. 2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867328666210827152914 YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
  12. 2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867327999201116193126 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.1%
  13. 2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867327999201116193126 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.2%
  14. 2019 Proteomics Analysis of CA1 Region of the Hippocampus in Pre-, Progression and Pathological Stages in a Mouse Model of the Alzheimer's Disease CURRENT ALZHEIMER RESEARCH DOI 10.2174/1567205016666190730155926 YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.2%
  15. 2018 Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model JOURNAL OF ALZHEIMERS DISEASE DOI 10.3233/JAD-170329 YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.6%
  16. 2018 Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model JOURNAL OF ALZHEIMERS DISEASE DOI 10.3233/JAD-170329 YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.7%
  17. 2023 Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine BIOMEDICINE & PHARMACOTHERAPY DOI 10.1016/j.biopha.2022.114111 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.1%
  18. 2022 Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain Molecular Omics DOI 10.1039/d1mo00440a YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
  19. 2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867328666210827152914 YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
  20. 2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer\u2019s Disease in Mouse Model Current Medicinal Chemistry DOI 10.2174/0929867327999201116193126 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.2%

Back to academicians